Xu, Y., Wang, X., Sun, C., Gao, Z., He, H., Qiu, S., . . . Ma, K. A phase II study of antiangiogenic therapy (Apatinib) plus chemotherapy as second‐line treatment in advanced small cell lung cancer. Wiley.
Chicago Style (17th ed.) CitationXu, Yinghui, et al. A Phase II Study of Antiangiogenic Therapy (Apatinib) Plus Chemotherapy as Second‐line Treatment in Advanced Small Cell Lung Cancer. Wiley.
MLA (9th ed.) CitationXu, Yinghui, et al. A Phase II Study of Antiangiogenic Therapy (Apatinib) Plus Chemotherapy as Second‐line Treatment in Advanced Small Cell Lung Cancer. Wiley.
Warning: These citations may not always be 100% accurate.